|
|
|
Gout Clinical Trials, Diagnosis, and Treatment |
|
Thank you for your interest in clinical trials for Gout.
Please click "Search" to find Gout clinical trials and medical research studies
or read below for information on Gout diagnosis and treatment.
If you receive too many study listings you may enter your zip code to find the
locations closest to you.
|
|
|
|
|
Results from Clinical Connection:
|
|
|
|
Your search returned 27 studies:
|
|
|
|
|
Results from other databases:
|
|
|
|
Your search returned 140 studies:
- Allopurinol Combination Study - NCT01001338-20902
Conditions: Gout Location: Wheaton, MD
- Allopurinol Combination Study - NCT01001338-23320
Conditions: Gout Location: Chesapeake, VA
- Allopurinol Combination Study - NCT01001338-27710
Conditions: Gout Location: Durham, SC
- Allopurinol Combination Study - NCT01001338-29732
Conditions: Gout Location: Rock Hill, SC
- Allopurinol Combination Study - NCT01001338-32720
Conditions: Gout Location: DeLand, FL
- Allopurinol Combination Study - NCT01001338-33334
Conditions: Gout Location: Fort Lauderdale, FL
- Allopurinol Combination Study - NCT01001338-33432
Conditions: Gout Location: Boca Raton, FL
- Allopurinol Combination Study - NCT01001338-33458
Conditions: Gout Location: Jupiter, FL
- Allopurinol Combination Study - NCT01001338-38138
Conditions: Gout Location: Germantown, TN
- Allopurinol Combination Study - NCT01001338-44122
Conditions: Gout Location: Cleveland, OH
- Allopurinol Combination Study - NCT01001338-44143
Conditions: Gout Location: Mayfield Village, OH
- Allopurinol Combination Study - NCT01001338-77074
Conditions: Gout Location: Houston, TX
- Allopurinol Combination Study - NCT01001338-78221
Conditions: Gout Location: San Antonio, TX
- Allopurinol Combination Study - NCT01001338-83642
Conditions: Gout Location: Boise, ID
- Allopurinol Combination Study - NCT01001338-84088
Conditions: Gout Location: West Jordan, UT
- Allopurinol Combination Study - NCT01001338-85050
Conditions: Gout Location: Phoenix, AZ
- Allopurinol Combination Study - NCT01001338-85224
Conditions: Gout Location: Chandler, AZ
- Allopurinol Combination Study - NCT01001338-89183
Conditions: Gout Location: Las Vegas, NV
- Allopurinol Combination Study - NCT01001338-89502
Conditions: Gout Location: Reno, NV
- Allopurinol Combination Study - NCT01001338-90017
Conditions: Gout Location: Los Angeles, CA
- Allopurinol Combination Study - NCT01001338-92037
Conditions: Gout Location: La Jolla, CA
- Allopurinol Combination Study - NCT01001338-94305
Conditions: Gout Location: Stanford, CA
- An Assessment of Chronic Synovial-Based Inflammation and Its Role With Serum Urate Levels. - NCT01112982-33612
Conditions: Gout Location: Tampa, FL
- Apremilast Therapy for Acute Gouty Arthritis - NCT00997581-03756
Conditions: Acute Gout Location: Lebanon, NH
- Assessment of Primary Care Providers' Knowledge and Beliefs Regarding Gout Management - NCT01151709-01566
Conditions: Gout Location: Worcester, MA
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-02453
Conditions: Acute Gout Location: Waltham, MA
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-02864
Conditions: Acute Gout Location: Cumberland, RI
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-06810
Conditions: Acute Gout Location: Danbury, CT
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-07728
Conditions: Acute Gout Location: Freehold, NJ
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-08903
Conditions: Acute Gout Location: New Brunswick, NJ
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-11201
Conditions: Acute Gout Location: Brooklyn, NY
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-16635
Conditions: Acute Gout Location: Duncansville, PA
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-19104
Conditions: Acute Gout Location: Philadelphia, PA
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-20902
Conditions: Acute Gout Location: Wheaton, MD
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-23606
Conditions: Acute Gout Location: Newport News, VA
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-24541
Conditions: Acute Gout Location: Danville, VA
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-28150
Conditions: Acute Gout Location: Shelby, NC
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-28209
Conditions: Acute Gout Location: Charlotte, NC
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-28277
Conditions: Acute Gout Location: Charlotte, NC
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-28602
Conditions: Acute Gout Location: Hickory, NC
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-29204
Conditions: Acute Gout Location: Columbia, SC
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-29407
Conditions: Acute Gout Location: Charleston, SC
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-29412
Conditions: Acute Gout Location: Charleston, SC
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-29601
Conditions: Acute Gout Location: Greenville, SC
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-29944
Conditions: Acute Gout Location: Varnville, SC
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-30035
Conditions: Acute Gout Location: Decatur, GA
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-30344
Conditions: Acute Gout Location: East Point, GA
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-33028
Conditions: Acute Gout Location: Pembroke Pines, FL
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-33458
Conditions: Acute Gout Location: Jupiter, FL
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-33614
Conditions: Acute Gout Location: Tampa, FL
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-33756
Conditions: Acute Gout Location: Clearwater, FL
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-33782
Conditions: Acute Gout Location: Pinellas Park, FL
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-35294
Conditions: Acute Gout Location: Birmingham, AL
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-36207
Conditions: Acute Gout Location: Anniston, AL
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-36608
Conditions: Acute Gout Location: Mobile, AL
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-37043
Conditions: Acute Gout Location: Clarksville, TN
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-37601
Conditions: Acute Gout Location: Johnson City, TN
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-37620
Conditions: Acute Gout Location: Bristol, TN
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-38301
Conditions: Acute Gout Location: Jackson, TN
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-38305
Conditions: Acute Gout Location: Jackson, TN
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-39202A
Conditions: Acute Gout Location: Jackson, MS
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-39202B
Conditions: Acute Gout Location: Jackson, MS
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-39209
Conditions: Acute Gout Location: Jackson, MS
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-43215
Conditions: Acute Gout Location: Columbus, OH
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-44094
Conditions: Acute Gout Location: Willoughby Hills, OH
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-44501
Conditions: Acute Gout Location: Youngstown, OH
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-45417
Conditions: Acute Gout Location: Dayton, OH
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-48085
Conditions: Acute Gout Location: Troy, MI
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-48346
Conditions: Acute Gout Location: Clarkston, MI
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-48532
Conditions: Acute Gout Location: Flint, MI
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-48910
Conditions: Acute Gout Location: Lansing, MI
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-49546
Conditions: Acute Gout Location: Grand Rapids, MI
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-59808
Conditions: Acute Gout Location: Missoula, MT
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-62704
Conditions: Acute Gout Location: Springfield, IL
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-66215
Conditions: Acute Gout Location: Overland Park, KS
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-66606
Conditions: Acute Gout Location: Topeka, KS
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-67208
Conditions: Acute Gout Location: Wichita, KS
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-68134
Conditions: Acute Gout Location: Omaha, NE
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-70006
Conditions: Acute Gout Location: Metairie, LA
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-70508
Conditions: Acute Gout Location: Lafayette, LA
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-70808
Conditions: Acute Gout Location: Baton Rouge, LA
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-71106
Conditions: Acute Gout Location: Shreveport, LA
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-71115
Conditions: Acute Gout Location: Shreveport, LA
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-71203
Conditions: Acute Gout Location: Monroe, LA
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-72205
Conditions: Acute Gout Location: Little Rock, AR
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-73103
Conditions: Acute Gout Location: Oklahoma City, OK
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-73109
Conditions: Acute Gout Location: Oklahoma City, OK
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-76180
Conditions: Acute Gout Location: North Richard Hills, TX
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-77004
Conditions: Acute Gout Location: Houston, TX
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-77058
Conditions: Acute Gout Location: Nassau Bay, TX
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-77566
Conditions: Acute Gout Location: Lake Jackson, TX
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-78229
Conditions: Acute Gout Location: San Antonio, TX
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-78232
Conditions: Acute Gout Location: San Antonio, TX
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-78641
Conditions: Acute Gout Location: Leander, TX
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-78758
Conditions: Acute Gout Location: Austin, TX
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-83702
Conditions: Acute Gout Location: Boise, ID
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-83704
Conditions: Acute Gout Location: Boise, ID
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-85741
Conditions: Acute Gout Location: Tucson, AZ
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-89183
Conditions: Acute Gout Location: Las Vegas, NV
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-90650
Conditions: Acute Gout Location: Norwalk, CA
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-90806
Conditions: Acute Gout Location: Long Beach, CA
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-91108
Conditions: Acute Gout Location: San Marino, CA
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-91505
Conditions: Acute Gout Location: Burbank, CA
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-91767
Conditions: Acute Gout Location: Pomona, CA
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-91790
Conditions: Acute Gout Location: West Covina, CA
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-92008
Conditions: Acute Gout Location: Carlsbad, CA
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-92083
Conditions: Acute Gout Location: Vista, CA
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-92103
Conditions: Acute Gout Location: San Diego, CA
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-92108
Conditions: Acute Gout Location: San Diego, CA
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-92117
Conditions: Acute Gout Location: San Diego, CA
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-92701
Conditions: Acute Gout Location: Santa Ana, CA
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-92780
Conditions: Acute Gout Location: Tustin, CA
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-95628
Conditions: Acute Gout Location: Fair Oaks, CA
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-95661
Conditions: Acute Gout Location: Roseville, CA
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine - NCT01137344-95816
Conditions: Acute Gout Location: Sacramento, CA
- Cardiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular Comorbidities - NCT01101035-
Conditions: Acute Coronary Syndrome - Gout Location: Weston, WI
- Effect of Febuxostat on Joint Damage in Hyperuricemic Subjects With Early Gout - NCT01078389-
Conditions: Joint Damage Location: Kenosha, WI
- Effect of Febuxostat on Renal Function in Patients With Gout and Moderate to Severe Renal Impairment - NCT01082640-
Conditions: Renal Impairment Location: Wauwatosa, WI
- Review of Safety Using Rilonacept in Preventing Gout Exacerbations (RE-SURGE) - NCT00856206-
Conditions: Gout Location: Norfolk, VA
- Safety and Efficacy Study of Intramuscular Uricase-PEG 20 - NCT01038947-16635
Conditions: Gout - Hyperuricemia Location: Duncansville, PA
- Safety and Efficacy Study of Intramuscular Uricase-PEG 20 - NCT01038947-33143
Conditions: Gout - Hyperuricemia Location: Miami, FL
- Study to Evaluate sUA-Lowering Activity, Safety & PK Interaction of Oral BCX4208 & Allopurinol Admin. in Subjects w/Gout - NCT01129648-16635
Conditions: Gout Location: Duncansville, PA
- Study to Evaluate sUA-Lowering Activity, Safety & PK Interaction of Oral BCX4208 & Allopurinol Admin. in Subjects w/Gout - NCT01129648-21702
Conditions: Gout Location: Frederick, MD
- Study to Evaluate sUA-Lowering Activity, Safety & PK Interaction of Oral BCX4208 & Allopurinol Admin. in Subjects w/Gout - NCT01129648-27609
Conditions: Gout Location: Raleigh, NC
- Study to Evaluate sUA-Lowering Activity, Safety & PK Interaction of Oral BCX4208 & Allopurinol Admin. in Subjects w/Gout - NCT01129648-28211
Conditions: Gout Location: Charlotte, NC
- Study to Evaluate sUA-Lowering Activity, Safety & PK Interaction of Oral BCX4208 & Allopurinol Admin. in Subjects w/Gout - NCT01129648-33143
Conditions: Gout Location: South Miami, FL
- Study to Evaluate sUA-Lowering Activity, Safety & PK Interaction of Oral BCX4208 & Allopurinol Admin. in Subjects w/Gout - NCT01129648-37620
Conditions: Gout Location: Bristol, TN
- Study to Evaluate sUA-Lowering Activity, Safety & PK Interaction of Oral BCX4208 & Allopurinol Admin. in Subjects w/Gout - NCT01129648-38654
Conditions: Gout Location: Olive Branch, MS
- Study to Evaluate sUA-Lowering Activity, Safety & PK Interaction of Oral BCX4208 & Allopurinol Admin. in Subjects w/Gout - NCT01129648-40504
Conditions: Gout Location: Lexington, KY
- Study to Evaluate sUA-Lowering Activity, Safety & PK Interaction of Oral BCX4208 & Allopurinol Admin. in Subjects w/Gout - NCT01129648-57702
Conditions: Gout Location: Rapid City,
- Study to Evaluate sUA-Lowering Activity, Safety & PK Interaction of Oral BCX4208 & Allopurinol Admin. in Subjects w/Gout - NCT01129648-59107
Conditions: Gout Location: Billings, MT
- Study to Evaluate sUA-Lowering Activity, Safety & PK Interaction of Oral BCX4208 & Allopurinol Admin. in Subjects w/Gout - NCT01129648-68134
Conditions: Gout Location: Omaha, NE
- Study to Evaluate sUA-Lowering Activity, Safety & PK Interaction of Oral BCX4208 & Allopurinol Admin. in Subjects w/Gout - NCT01129648-75235
Conditions: Gout Location: Dallas, TX
- Study to Evaluate sUA-Lowering Activity, Safety & PK Interaction of Oral BCX4208 & Allopurinol Admin. in Subjects w/Gout - NCT01129648-83704
Conditions: Gout Location: Boise, ID
- Study to Evaluate sUA-Lowering Activity, Safety & PK Interaction of Oral BCX4208 & Allopurinol Admin. in Subjects w/Gout - NCT01129648-85251
Conditions: Gout Location: Scottsdale, AZ
- Study to Evaluate sUA-Lowering Activity, Safety & PK Interaction of Oral BCX4208 & Allopurinol Admin. in Subjects w/Gout - NCT01129648-87106
Conditions: Gout Location: Albuquerque, NM
- Study to Evaluate sUA-Lowering Activity, Safety & PK Interaction of Oral BCX4208 & Allopurinol Admin. in Subjects w/Gout - NCT01129648-89502
Conditions: Gout Location: Reno, NV
- Study to Evaluate sUA-Lowering Activity, Safety & PK Interaction of Oral BCX4208 & Allopurinol Admin. in Subjects w/Gout - NCT01129648-92618
Conditions: Gout Location: Irvine, CA
- Study to Evaluate sUA-Lowering Activity, Safety & PK Interaction of Oral BCX4208 & Allopurinol Admin. in Subjects w/Gout - NCT01129648-96814
Conditions: Gout Location: Honolulu, HI
- Tranilast Plus Allopurinol in Patients With Moderate to Severe Gout (TAnGO) - NCT01109121-
Conditions: Moderate to Severe Gout - Hyperuricemia Location: Spokane, WA
|
|
|
|
|
Didn't find what you were looking for? Try these alternatives:
Become A Member: To be notified of upcoming clinical trials in your
area please create a free member account.
Browse Studies: If you would like to browse all featured clinical trials
please Browse Studies.
Message Board: Join the discussion in our Health
and Clinical Trials Message Board.
|
|
|